CRISPR Gene-Editing Shows Promise in Removing SIV in Non-Human Primates

Key Points:

– Scientists have successfully used CRISPR gene-editing to remove SIV, a virus related to HIV, from the genomes of non-human primates.
– This breakthrough paves the way for the first-ever clinical trial of an HIV gene-editing treatment in humans.
– The FDA has approved the clinical trial, which is set to take place in the near future.

Hot take:

In a major step forward for HIV research, scientists have now shown that CRISPR gene-editing can safely and effectively remove SIV, a virus related to HIV, from the genomes of non-human primates. This groundbreaking work sets the stage for the first-ever clinical trial of an HIV gene-editing treatment in humans, which has been authorized by the FDA. With this innovative technology, there is hope for a future where HIV can be effectively treated or even eliminated from infected individuals.

Original article: https://www.sciencedaily.com/releases/2023/08/230817164016.htm